SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers Health is trending as chatter swirls around a recent SEC filing showing the CEO sold a significant number of shares, sparking debate about potential conflicts of interest and motives behind the sale. Some traders are taking bearish stances and pointing to potentially overvalued conditions, while bulls are hoping the stock can shake off the negative sentiment with its expansion into the menopause market and potential short squeeze.

Artiva Biotherapeutics, Inc. operates as a biotechnology company for the treatment of hematologic cancers. It offers NK cell therapies for cancer. The company was founded by Thomas J. Farrell in 2019 and is headquartered in San Diego, CA.

Artiva Biotherapeutics Inc

ARTV is trending due to positive sentiment around potential upgrades and community excitement about its gains, with some eyeing a move to double digits. Bullish traders are celebrating recent wins and expressing confidence in the stock's undervaluation, citing Wedbush's price target. However, some caution exists regarding potential pullbacks, with a few traders closing positions for profit.

Firecoin is a digital asset inspired by the concept of the eternal flame, representing energy, resilience, and guidance. It is designed to act as a decentralized token that embodies light and strength, giving holders a sense of empowerment in the digital economy. The project’s purpose is to create a community-driven ecosystem where Firecoin symbolizes progress, illumination, and the ability to move forward regardless of challenges. By leveraging blockchain technology, Firecoin aims to provide transparency, security, and accessibility to its users while maintaining its thematic connection to the symbolic power of fire.

firecoin

$FIRECOIN is experiencing a surge in interest, with community members actively discussing its availability on Phantom Wallet and potential for high gains. The conversation is centered around whether it's a legitimate opportunity or a 'scam,' with some users reporting significant gains while others express skepticism. Many are using Phantom Wallet to monitor activity and track the token's performance relative to other cryptocurrencies like $BTC and $SOL.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

QQQ is trending as traders weigh positive catalysts like potential US-China trade talks against concerns about high valuations and regional banking risks. Community discussions focus on whether the current market action is a bull trap or the start of a sustained rally, with many observing unusual price swings and questioning the influence of algorithmic trading. Some traders are pointing to Trump's comments on China and potential interest rate cuts as bullish signals, while others remain cautious, citing overbought conditions and a potential for a pullback.

SPDR Gold Trust - SPDR Gold Shares ETF

SPDR Gold Shares ETF

GLD is trending as it hits new highs, driven by factors like safe-haven demand amid economic uncertainty and speculation around potential Federal Reserve actions. Community discussions revolve around whether this rally is sustainable or if a pullback is imminent, with some highlighting potential overbought conditions while others point to continued global instability as support. Broader market context includes concerns about the dollar's devaluation and the possibility of gold replacing US Treasuries as a reserve asset.

RAGE GUY (RAGE) is a cryptocurrency inspired by the Rage Guy meme, one of the earliest and most recognizable characters from internet rage comics. The project captures the cultural legacy of early meme history and brings it onto the blockchain in tokenized form. It is designed as a community-driven digital asset that celebrates internet culture, nostalgia, and the role memes play in shaping online communities.

Rage Guy

RAGE CRYPTO is trending as the community rallies around the iconic Rage Guy meme, expressing strong bullish sentiment and anticipating potential listings. Discussions revolve around community building, 'WAGMI' (We're All Gonna Make It) spirit, and embracing the OG meme culture. The community is actively participating in raids and spaces.

SSgA Active Trust - SPDR S&P 500 ETF Trust

The SPY is trending as traders digest potential shifts in US-China trade relations following comments from former President Trump, contributing to market volatility. Community discussions revolve around identifying key support and resistance levels, with some expressing skepticism about the market's overall strength. Traders are also monitoring the impact of potential bank failures and geopolitical events on the ETF's performance.

Carvana Co. is a holding company and an eCommerce platform, which engages in the buying and selling of used cars. The company was founded by Ernest Garcia, III, Benjamin Huston and Ryan Keeton in 2012 and is headquartered in Tempe, AZ.

Carvana Co. - Ordinary Shares - Class A

Carvana Co.

Carvana is trending amid discussions about its financial health and potential connection to broader issues in the subprime auto loan market, with community members pointing to insider selling and concerns about the company's accounting practices. Bears are highlighting potential downside risks, while bulls debate whether the stock presents a buying opportunity or a value trap. The stock's volatile price action and upcoming earnings are adding to the intense debate.

Nektar Therapeutics is a biotechnology company, which engages in the discovery and development of novel therapies which selectively modulate the immune system to treat autoimmune disorders. It also focuses on immunology and unparalleled expertise in polymer chemistry to create one-of-a-kind, highly-selective medicines with optimal therapeutic benefit. The company was founded in 1990 and is headquartered in San Francisco, CA.

Nektar Therapeutics

Nektar Therapeutics is trending amid rumors of a potential acquisition by Eli Lilly ($LLY), fueled by mentions in the Betaville blog and community speculation around trial updates and a possible settlement.  The community is buzzing about the acquisition potential and upcoming trial results, with many suggesting a settlement could be imminent. Bullish sentiment is further supported by a price target increase from B. Riley Securities.

VisionWave Holdings, Inc. engages in the forefront of revolutionizing defense capabilities by integrating advanced artificial intelligence (AI) and autonomous solutions across air, ground, and sea domains. The company was founded on September 3, 2024 and is headquartered in Wilmington, DE.

VisionWave Holdings Inc.

VisionWave Holdings, Inc.

VisionWave is trending as traders discuss a potential breakout above the $12.50 resistance, with some pointing to the stock's low float and potential in the AI and defense sectors. Community members are also eyeing call options, anticipating a significant move, while others highlight the company's AI, drone, and sensing technologies, drawing comparisons to $PLTR. Chatter also mentions a recent advisory board formation and successful UAE live-fire trial as potential catalysts.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Here's Why Halozyme Therapeutics (HALO) is a Strong Value Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Halozyme Rallies Almost 40% YTD: How Should You Play the Stock?

HALO's nearly 40% YTD surge is fueled by higher ENHANZE royalties. The Elektrofi deal also positions the company for long-term diversification.

Can Elektrofi Acquisition Drive Halozyme's Long-Term Growth?

HALO's impending acquisition of Elektrofi will add Hypercon tech to broaden its drug delivery platform and support long-term growth.

Are Medical Stocks Lagging  Armata Pharmaceuticals (ARMP) This Year?

Here is how Armata Pharmaceuticals, Inc. (ARMP) and Halozyme Therapeutics (HALO) have performed compared to their sector so far this year.

AbbVie Seeks FDA Nod for Tavapadon to Treat Parkinson's Disease

ABBV files for FDA approval of tavapadon, a once-daily oral Parkinson's drug backed by late-stage TEMPO studies.

Encompass Health Opens First Connecticut Rehab Hospital in Danbury

EHC opens its first Connecticut rehab hospital in Danbury, boosting its nationwide expansion and meeting rising demand for specialized care.

HRMY Stock Down as Fragile X Syndrome Study Fails to Meet Goal

Harmony Biosciences' shares plunge after ZYN002 failed in Fragile X, but Wakix sales and new epilepsy assets keep its pipeline moving forward.

Why Halozyme Therapeutics (HALO) is a Top Value Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

BMY Reports Positive Data From a Late-Stage Multiple Myeloma Study

Bristol Myers reports positive phase III results for iberdomide in multiple myeloma, advancing its CELMoD pipeline and portfolio expansion.

Powell Warns of Valuation Risks: 5 High Earnings Yield Value Picks 

Powell flags lofty valuations, but five high-earnings-yield stocks stand out as value picks in a cautious market.

Halozyme Therapeutics, Inc. is a biopharmaceutical technology platform company. It engages in developing, manufacturing, and commercializing drug-device combination products using advanced auto-injector technology that are designed to provide commercial or functional advantages such as improved convenience and tolerability, and enhanced patient comfort and adherence. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA.

Halozyme Therapeutics Inc.

Will Netflix ($NFLX) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

Netflix Inc

) beat quarterly earnings? 
 
*Powered by Polymarket

Current Price	$67.14
Prev Close	$66.88
Open	$67.24
Dividend Yield	0.00%
50-Day Moving Average	$71.26
Beta	0.70
Avg. Volume	2.05M
PE Ratio	15.28

52-Week High	$79.50
52-Week Low	$42.01
Market Capitalization	$7.82B
EPS (Annual)	$3.43
Price to Book	23.64
Revenue Per Employee	$2.9M
Enterprise Value/EBITDA	N/A

HALO
Halozyme Therapeutics Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest HALO News

HALOHalozyme Therapeutics Inc.